Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Northrop Grumman (NOC)

Northrop Grumman Q2 EPS rises to $8.15 and 2025 guidance is raised

Positive Impact 4 of 5 earnings Written later

Northrop Grumman reported second quarter 2025 sales of $10.4 billion, up 1% from a year earlier, and diluted earnings per share of $8.15, up from $6.36. The results include a $1.04 per share benefit from the training services divestiture, and the company raised its 2025 guidance for segment operating income, adjusted EPS and free cash flow. Free cash flow for the quarter fell 42% to $637 million, so cash generation weakened even as earnings and guidance improved.

Key points

  • Q2 2025 sales rose 1% to $10.4 billion; diluted EPS was $8.15 versus $6.36 a year earlier
  • The divestiture of the training services business added a net after-tax benefit of $150 million, or $1.04 per diluted share
  • 2025 segment operating income guidance raised to $4,275 million to $4,375 million; MTM-adjusted EPS to $25.00 to $25.40
  • Q2 free cash flow was $637 million, down 42% from $1,105 million; the company returned over $700 million to shareholders in the quarter

The filing

CompanyNorthrop Grumman (NOC)
Form8-K, current report
Filed with the SECJul 22, 2025, 6:45 AM ET
Accession number0001133421-25-000047

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 22, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.